Y Sawada, Y Izumida, Y Takeuchi… - Biochemical and …, 2017 - pubmed.ncbi.nlm.nih.gov
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have both anti-diabetic and anti-obesity effects. However, the precise mechanism of the anti-obesity effect remains unclear. We …
Y Sawada, Y Izumida, Y Takeuchi, Y Aita… - Biochemical and …, 2017 - europepmc.org
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have both anti-diabetic and anti-obesity effects. However, the precise mechanism of the anti-obesity effect remains unclear. We …
Y Sawada, Y Izumida, Y Takeuchi… - Biochemical and …, 2017 - u-toyama.elsevierpure.com
Abstract Sodium-glucose cotransporter 2 (SGLT2) inhibitors have both anti-diabetic and anti- obesity effects. However, the precise mechanism of the anti-obesity effect remains unclear …
[引用][C]Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry
Y Sawada, Y Izumida, Y Takeuchi, Y Aita, N Wada… - 2017